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ABSTRACT: Diabetes is one of the commonest global diseases affecting both sexes and phytomedicine is currently 
among the foremost replacements for orthodox drug; Polyalthia longifiola is among the locally used herbal remedies for 
various ailments. The onus of this research was to investigate the phytochemical constituents and potential of P. longifiola 
aqueous leaf extract against alterations in liver and kidney functions in rats injected with alloxan. Phytochemical 
evaluation of the aqueous plant leaf extract indicated that terpenes, non-reducing sugar, flavonoid, resin, phenol, gums 
and mucilage were present. The contents of total flavonoids and phenol in the plant leaf are 55.56 µg catechin equivalent/ 
g and 1.62 g/ 100g DW, respectively. The plant extract administered reduced the glucose concentration of the diabetic-
induced animals in a dose dependent manner. This reducing potential of glucose by the plant is as a consequence of the 
availability of these phytochemicals in the extract of the plant. Alterations in liver function biomarkers (serum ALP, ALT, 
AST, GGT, TB and DB) caused by the hyperglycemic state of the test animals were reversed as the extract was given to 
the diabetic rats. Kidney function makers such as creatinine, urea and uric acid were also reduced upon administration of 
hypoglycemic drug and aqueous plant extract and improved as time progressed. Thus P. longifiola (mast tree) aqueous 
leaf extract has ameliorative effects on liver and kidney functions of rats induced with diabetes and could be used in 
management of type 2 diabetes even at a concentration of 100 mg/kg bwt. 
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Diabetes is one of the popular global diseases affecting 
both sexes. It is estimated that about 1.5 million 
persons died directly from diabetes in 2012 (WHO, 
2016a) and statistics of year 2014 showed that 422 
million adults were living with diabetes with a larger 
percentage from West African region and South East 
Asia (WHO, 2016b). Diabetes occurs because of 
insensitivity of the cells to insulin produced or 
insufficient secretion of insulin by the pancreas 
(Gaikwad et al., 2014). Application of plant in the 
remediation of ailment is practiced in the African 
region and even Western region, according to Gihyun 
and Hyunsu (2017).  Phytomedicine currently is 
among the foremost replacements for orthodox drug. 
Polyalthia longifiola (the mast tree) is commonly used 
in beautification of surrounding; the mast tree is 
commonly referred to as Ashoka in India because of 
its close resemblance with the Ashoka tree (Katkar et 
al., 2010) and in Nigeria it is commonly referred to as 
a masquerade tree because of its shape. Beyond its 
usage for horticulture it is also used in India and other 
African countries as a source of herbal treatment for 
hypertension among other maladies. The antimicrobial 
and antiulcer potential of the P. longifolia have already 
been confirmed in previous research (Sumitra et al., 
2011). The purpose of this work was to investigate the 
phytochemical constituents and potential of P. 
longifiola aqueous leaf extract against alterations in 
hepatic and renal functions in alloxan-induced diabetic 
rats. 
 
MATERIALS AND METHODS 
Experimental Animals: Adult male rats that were used 
in the work were of the weight range of 100-200g. 
They were bought from the animal house, Faculty of 
Basic Medical Sciences, Delta State University, 
Abraka, Nigeria and then fed for a period of one week 
with grower marsh purchased from Dutch Farm 
Limited, Abraka and water ad libitum. Diabetes was 
induced in these animals by the injection of alloxan 
monohydrate which caused hyperglycemia via the 
destruction of the pancreas. 
 
Chemicals: All reagents and the alloxan monohydrate 
used for this research were bought from Alpha 
Chimika, Mumbia, China. 
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Collection and Identification of Plant Material: 
Leaves of mast tree (Polyalthia longifiola) were 
collected from Ovu-Inland, Delta State and identified 
in the Department of Botany, Delta State University, 
Abraka, Delta State, Nigeria. 
 
Preparation of Extract: The obtained plant leaves 
were washed with water and then air-dried for three 
weeks. These were grinded to power form with the 
help of Waren blender. 800g of powdered solute (P. 
longifiola) was immersed in 3200ml (3.2L) of distilled 
water (1:4 ratio). It was marinated for 48hrs to obtain 
the crude extract. This was followed by filtration using 
Whatman No110 filter paper. The supernatant (filtered 
crude) was then concentrated using a vacuum rotary 
evaporator at 50oC and water bathe at 40oC. This 
extract concentrate, which was dark in colour and 
weighed 141.88g (17.7%w/w), was packaged in an 
airtight plastic container and stored at 4oC until when 
required for use.   
 
Induction of Diabetes: The rats were starved for 12 
hours and 150mg/kg alloxan monohydrate solution 
was administered intraperitoneally. Main while, the 
fasting blood glucose level (FBGL) was recorded 
using glucometer before the induction to know the 
glucose levels. The alloxan monohydrate solution was 
prepared by dissolving 4g of alloxan in 100ml of 
normal saline (40mg/ml.). After 72 hours of alloxan 
monohydrate injection, blood glucose level of over 
200mg/dl was recorded which is an indication of 
hyperglycemic state (Iweala et al., 2013; Islam et al., 
2015). 
 
Experimental design: The design of the study is as 
shown in Table 1. 
Table 1: Grouping of experimental rats and administered 
treatment. 
Group Treatment 
NC Negative control (Healthy rats + no 
treatment) 
PC Positive control (Diabetic rats + no treatment) 
F1  Diabetic rats + 100 mg/kg  of extract of 
Polyalthia longifiola 
F2 Diabetic rats + 200 mg/kg  of extract of P. 
longifiola 
F3  Diabetic rats + 300 mg/kg  of extract of P. 
longifiola 
STD Diabetic rats + 100 mg/kg of hypoglycermic 
drug (Metformin) 
 
Phytochemical screening: Preliminary phytochemical 
screening of aqueous leaf extract of P. longifiola was 
carried out using standard methods as described by 
Njoku and Obi (2009), Borokini and Omotayo (2012), 
Anigboro et al. (2014) and Tonukari et al., (2015) to 
screen for the presence of various chemical 
constituents. 
Determination of Biochemical Parameters: 
Determination/Estimation of liver enzymes, lipid 
profile and kidney function were carried out using the 
Prietest easylab Biochemistry analyzer. It measures 
theoretical densities of samples and it uses algorithm 
to calculate results, which are used for biochemical 
investigations. Serum Glucose, Urea, Creatinine, 
Alanine aminotransferase (ALT), Aspartate 
aminotransferase (AST), Total Bilirubin (TB), Direct 
Bilirubin (DB), Alkaline Phosphatase (ALP), Uric 
Acid, Urea, and Gamma glutamyltransferase (GGT), 
were assayed using Prietest easylab Biochemical 
analyzer. 
 
Statistical Analysis: The data was analyzed using a 
computer software (SPSS version 21) and compared 
using Bonferroni post hoc test. The results were 
represented as Mean ± SD. Values in tables carrying 
different superscript letters (a,b,c,d,e) within a column 
or row are considered statistically significantly 
different (P<0.05) while those with the same letter are 
not (P>0.05). 
 
RESULTS AND DISCUSSION 
Based on the phytochemical evaluation of Polyalthia 
longifiola, the presence of terpenes and non-reducing 
sugar was observed with mild detection of flavonoid, 
resin, phenol, gums and mucilage (Tables 2a and 2b). 
In the management of diabetes mellitus, one approach 
is the slowing down of glucose absorption through 
reduction in carbohydrate catabolism in the intestine 
by inhibiting hydrolyzing enzymes of carbohydrate 
such as α-amylases, α-glucosidases and maltase 
(Hamden et al., 2013). Terpenes such as triterpenes are 
effective in inhibiting α-glucosidases and α-amylases 
(Nazaruk and Borzym-Kluczyk, 2015). Aldose 
reductase inhibition is another means through which 
terpenes are used in the upkeep of diabetes; aldose 
reductase is involved in polyol pathway also called 
sorbitol-aldose reductase pathway responsible for the 
catabolism of un-phosphorylated glucose. The 
metabolism of glucose through the sorbitol-aldose 
reductase is greatly increased in hyperglycemic state 
and it results to microvascular complications in 
diabetes (Petrash, 2004). In a diabetic state, the 
quantity of free radical generated increases leading to 
a reduction of the antioxidant capacity of the body 
(Rahimi et al., 2005). Terpenes function to boost the 
antioxidant potential of the body (Tonukari et al., 
2013; Anigboro et al., 2014; Tonukari et al., 2015; 
Aganbi et al., 2017). Liver and renal dysfunction is 
linked with metabolic disorder. Previous findings have 
proven that Polyalthia longifiola leaves and stem 
extract elicit its action through anti-hyperglycemic 
activity and inhibition of α-glucosidase and α-amylase 
(Gosh et al., 2010; Sivashanmugam and Chatterjee, 
Phytochemical Constituents, Antidiabetic…..                                                                                                    995 
 
ANIGBORO, AA; AVWIOROKO, OJ; OHWOKEVWO, OA; NZOR, JN 
 
2013). Phenolic compounds including flavonoids and 
phenol from plants serve as natural antioxidants and 
hence are also important in the treatment of diabetes 
as phenols and flavonoids have the ability to inhibit 
digestion enzymes like α-amylase and α-glucosidase 
required in the catabolism of complex carbohydrate to 
glucose (Lin et al., 2016).  Mucilage derived from 
plant has long been employed in Persian world for 
treatment of various ailments including type 1 diabetes 
through its inhibition of α-glucosidase and α-amylase. 
Mucilage also carries out antimicrobial activity etc 
(Ameri et al., 2014); mucuilage is important in drug 
delivery because of its binding and gelling potential 
alongside its sustaining capacity (Wadhwa et al., 
2013). 
 
Table 2a: Qualitative analysis of phytochemical constituents of 
Polyalthia longifiola leaf. 
 
+ = Mildly present; ++ = highly present; +++ = more highly 
present; - = Absent. The phytochemical evaluation of the mast tree 
leaf extract indicated that terpenes, non-reducing sugar, flavonoid, 
resin, phenol, gums and mucilage were present. 
 
Table 2b: Total phenol and flavonoid contents of 
Polyalthia longifiola leaf. 
 
The quantitative analysis showed that mast tree leaf is 
rich in total phenol (1.62 g/ 100g dry weight) and total 
flavonoids (55.56 µg catechin equivalent/ g). 
 
During the period of study, the elevated glucose level 
of the untreated diabetic rats remained within the same 
range while the diabetic treated rats’ glucose 
concentration decreased as the time of study 
progressed (Table 3); at each five-day interval the 
glucose concentration was lower than the previous 
five-day value. P. longifiola leaf extract reduced the 
glucose concentration in a dose dependent manner, 
higher dosage had better effect. The reduction in 
glucose level by plant extract and hypoglycemic drug 
in treated rats was markedly lower than in diabetic rats 
that were not treated at day 10 and day 15. This noticed 
reduction in the concentration of glucose indicates that 
the extract could be used in treatment of 
hyperglycemic condition and supports previous claims 
of the plant’s use in the upkeep of diabetes (Khan et 
al., 2013). Phytochemical composition of this plant 
has a lot to play in regards to the reduction in glucose 
concentration. As stated earlier, phenolic compounds 
and terpenes possesses the potential to inhibit α-
glucosidase and α-amylase which are required in the 
breakdown of carbohydrate to glucose, these 
phytochemicals present in P. longifiola also have 
antioxidant ability to protect the cells from increased 
free radicals caused by oxidative stress due to the 
diabetic state. The activity of ALT (alanine 
aminotransferase) in the blood of test rats at the end of 
experiment showed decrease in activity when 
compared against the untreated diabetic rats; the 
higher dosage had a better impact (Table 4). Levels of 
liver function enzymes (ALT, AST, ALP and GGT) 
were significantly increased (P<0.05) in the untreated 
diabetic rats (PC) compared to the healthy control 
group (NC). Administration of P. longifiola aqueous 
leaf extract to the diabetic rats, however, led to 
significant (P<0.05) decrease in levels of these 
enzymes in groups F1, F2 and F3. Bilirubin levels in 
the treated diabetic group rats (F1, F2 and F3) were 
also reduced compared to the untreated group (PC) 
though not significantly (P>0.05). The diabetic 
experimental animals treated with hypoglycemic drug 
had a lower level of ALT, even lower than that of the 
normal rats (negative control) and significantly lower 
than all groups. AST (aspartate aminotransferase) 
activity of test diabetic rats given aqueous leaf extract 
of P. longifiola was noticeably lower than the diabetic 
rats without treatment and normal rats while diabetic 
rats treated with hypoglycemic drug had the least 
activity of AST and significantly different from all 
groups (Table 4). 
ALP (alkaline phosphatase) activity of diabetic rats 
treated with plant extract and hypoglycemic drug 
reduced when compared against untreated diabetic rats 
and the reduction was significantly different (Table 4). 
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Table 3: Hypoglycermic effect of P. longifiola aqueous leaf extract on alloxan-induced diabetic rats 
Group Day 1 (mg/dl) Day 5 (mg/dl) Day 10 (mg/dl) Day 15 (mg/dl) 
NC 85.33 ± 19.7a 87.00 ± 16.5a 89.33 ± 12.9a 91.33 ± 10.1a 
PC 360.00 ± 28.2b 355.67 ± 28.9b 356.67 ± 24.9b 353.33 ± 25.9c 
F1  358.33 ± 7.64b 304.33 ± 5.13c 249.67 ± 7.64d 193.67 ± 4.51e 
F2  364.67 ± 5.03b 309.67 ± 5.03c 249.67 ± 4.16d 195.33 ± 4.04e 
F3 358.33 ± 5.13b 277.67 ± 8.08c 229.67 ± 14.0d 168.33 ± 3.06e 
STD 335.67 ± 13.6b 290.00 ± 8.72c 247.33 ± 6.35d 202.00 ± 4.00e 
Values are expressed in Mean± Standard error of mean. F1 = P. longifiola aqueous extract concentration at 100mg/kgbwt, F2 = 
200mg/kgbwt, F3 = 300mg/kgbwt, STD = Standard antidiabetic drug (Metformin) given at 100 mg/kgbwt. The plant extract administered 
reduced elevated glucose level of the diabetic animals in groups F1, F2 and F3 in a dose dependent manner and also with respect to 
duration of administration from Day 1 to 15. 
 
Table 4. Effect of P. longifiola aqueous leaf extract treatment on liver function biomarkers in alloxan-induced diabetic rats. 
GROUP  ALT (U/L) AST (U/L) ALP (U/L) GGT (U/L) TB (mg/dl) DB (mg/dl) 
NC 33.00 ± 2.65a 46.40 ± 4.06a 54.00 ± 3.12a 56.27 ± 9.65a 1.23 ± 0.67a 1.83 ± 1.02a 
PC 44.02 ± 0.43b 55.32 ± 0.64b 69.33 ± 0.58b 70.27 ± 1.57b 3.92 ± 0.06b 1.72 ± 0.03b 
F1  23.50 ± 1.32a 31.30 ± 1.10c 58.43 ± 1.01a 72.43 ± 1.70b 3.10 ± 0.10b 1.43 ± 0.12b 
F2  25.53 ± 0.50a 37.50 ± 0.85c 58.80 ± 1.45a 76.67 ± 0.58b 2.10 ± 0.17b 2.20 ± 0.15b 
F3 21.80 ± 2.00a 35.43 ± 0.60c 50.77 ± 2.25a 72.13 ± 1.85b 2.17 ± 0.06b 1.03 ± 0.25b 
STD 17.43 ± 1.15c 23.00 ± 2.60d 50.40 ±9.01a 52.43 ±2.02c 1.03 ± 0.23a 0.57 ± 0.23a 
ALT, Alanine aminotransferase; AST, aspartate aminotransferase; ALP, alkaline phosphatase; GGT, gamma glutarmyltransferase; TB, total 
bilirubin; DB, direct bilirubin level. Levels of liver function enzymes (ALT, AST, ALP and GGT) were significantly increased (P<0.05) in the 
untreated diabetic rats (PC) compared to the healthy control group (NC). Administration of P. longifiola aqueous leaf extract to the diabetic 
rats, however, led to significant (P<0.05) decrease in levels of these enzymes in groups F1, F2 and F3. Bilirubin levels in both untreated (PC) 
and treated diabetic group rats (F1, F2,) increased (P<0.05) compared to the negative control group (NC). 
 
Table 5: Effect of P. longifiola aqueous extract treatment on serum creatinine, urea and uric acid levels in alloxan-induced diabetic rats. 
Group Creatinine (mg/dl) Urea (mg/dl) Uric acid (mg/dl) 
NC 2.23 ± 0.81a 18.73 ± 2.37a 3.23 ± 0.32a 
PC 4.70 ± 0.06b 40.33 ± 0.58b 6.37 ± 0.15b 
F1  2.10 ± 0.10a 25.67 ± 1.14a 5.43 ± 0.21b 
F2  2.23 ± 0.15a 21.40 ± 0.62a 5.57 ± 0.91b 
F3 2.00 ± 0.20a 24.73 ± 5.6a 4.57 ± 0.06b 
STD 1.30 ± 0.17a 23.00 ±2.00a 3.83 ± 0.12a 
The significantly increased levels of serum creatinine and serum urea in the untreated diabetic animal group (PC) compared to the healthy 
control group (NC) were significantly (P<0.05) reduced in groups (F1, F2, and F3) treated with the extract of P. longifiola. Serum uric acid 
levels in diabetic rats were also reduced by the plant extract intervention, though not significantly (P>0.05). 
 
Inducement of diabetes to the experimental animals 
resulted in an increase of GGT (gamma 
glutamyltransferase) activity, the GGT activity only 
reduced in diabetic animals treated with hypoglycemic 
drug which was markedly lower than all groups (Table 
4). Total bilirubin (TB) level and direct bilirubin (DB) 
were elevated in untreated diabetic rats and those 
treated with plant extract compared to the negative 
control, whereas the hypoglycemic drug treated group 
reduced significantly in TB and DB levels when 
correlated with those treated with plant extract and 
untreated diabetic rats (Table 4). The rise in serum 
level of liver function enzymes (serum ALT, AST, 
ALP and GGT) has been attributed to the damaged 
structural integrity of the liver (Asayama et al., 1994; 
Lee et al., 2016) as a result of a metabolic alteration 
that occurs in diabetic animals. Bilirubin acts as an 
antioxidant to mop off free radicals generated; in 
diabetic condition bilirubin guides against lipid 
peroxidation. Thus the elevated level of bilirubin in 
hyperglycemia state is a protective action of the body 
and bilirubin concentration is reduced as the 
concentration of glucose in the blood reduces or tends 
towards normal (Zhu et al., 2017). 
 
The result indicated a remarkable reduction in 
creatinine concentration of animals given the aqueous 
leaf extract as against the animals that were not 
administered the extract and also the reduction was a 
little bit lower than the negative control (Table 5). 
However, rats given hypoglycemic drug (Metformin) 
had decreased creatinine level than those given the 
mast tree leaf extracts although not significantly 
(P>0.05) and even had a lower creatinine 
concentration than the negative control. Uric acid 
concentration significantly increased for the diabetic 
untreated animal when compared to the negative 
control; administration of the P. longifiola aqueous 
leaf extract reduced the concentration in a dose 
dependent manner however the reduction was not 
significant when compared to the untreated diabetic 
animals (Table 5). Diabetic animals treated with 
hypoglycemic drug had reduced uric acid 
concentration significantly when compared to 
untreated diabetic animals and animals treated with the 
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P. longifiola aqueous leaf extract. Inducement of 
diabetes caused a great increase of urea concentration 
that was significantly different (P<0.05) from all 
groups. Administration of the extract and 
hypoglycemic drug reduced, non-significantly, the 
elevated urea concentration. The reduced urea 
concentration by the drug and aqueous leaf extract was 
not as low as that of the negative control.  
 
Hyperglyceamia is one of the main reasons of gradual 
renal damage. This improper functioning of the kidney 
leads to an elevation of urea in the blood (Ishraq, 
2014). Elevated serum concentration of creatinine and 
urea in diabetic state indicates destruction to the 
kidney. Serum uric acid has been proven to be 
associated with kidney disease; the reason behind high 
uric acid concentration in a diabetic patient might be 
as a result of the inhibition of reabsorption of uric acid 
in the proximal tubule (Pavani and Anoop, 2011). 
Based on the observed results of the study, P. 
longifiola (mast tree) aqueous leaf extract carries out 
ameliorative actions on the liver and kidney; this is 
evident through the ability of the plant aqueous extract 
to reduce and bring to normal range the concentration 
of creatinine, urea, uric acid and liver enzymes (ALP, 
AST, ALT and GGT) in the blood. The reduction in 
direct bilirubin and total bilirubin upon administration 
of plant extract to the diabetic animals also proves 
further that the plant extract carries out ameliorative 
action against alterations in liver and kidney functions 
in diabetic rats injected with alloxan; the plant aqueous 
leaf extract also exhibited ability to reduce glucose 
level in diabetic rats.  
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